Vicore Pharma Holding AB (VCRE)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $9.76
- As of
Kresmion compiles this page from VCRE's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Vicore Pharma Holding AB (VCRE): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-10-22.
See the full VCRE dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for VCRE on one page. Preview it with sample data, then open it live with a free account.
Preview the VCRE dossierActive events for VCRE
- mediumEarnings below estimates
Q2-2026: Missed consensus by 11.1%, EPS $-0.51 vs $-0.459 estimate
- mediumEarnings below estimates
Q4-2024: Missed consensus by 8.9% - EPS $-0.4 vs $-0.3672 estimate
- mediumEarnings below estimates
Q4-2025: Missed consensus by 20.3% - EPS $-0.54 vs $-0.4488 estimate
- mediumEarnings above estimates
Q1-2026: Beat consensus by 20.3% - EPS $-0.39 vs $-0.4896 estimate
FREE, NO ACCOUNT
Every event on VCRE, as it fires
New filings, 13F moves and cross asset events on VCRE land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, VCRE
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
Related tickers
Follow VCRE on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to VCRE for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.